ViroPharma Announces Restructuring of Operations
20 janv. 2004 09h45 HE
|
ViroPharma Incorporated
EXTON, Pa., Jan. 20, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has restructured its organization to focus its resources on the advancement and...
Michael Dougherty and William Claypool, MD Join ViroPharma's Board of Directors
16 janv. 2004 10h01 HE
|
ViroPharma Incorporated
EXTON, Pa., Jan. 16, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced today the election of Michael Dougherty and Dr. William Claypool to its board of directors. Mr. Dougherty is...
ViroPharma Announces Advancements In Its Hemorrhagic Fever Virus Biodefense Program
18 déc. 2003 07h30 HE
|
ViroPharma Incorporated
EXTON, Pa., Dec. 18, 2003 (PRIMEZONE) -- ViroPharma incorporated (Nasdaq:VPHM) today announced that it has discovered antiviral compounds active against a group of potential bioterrorism viruses...
ViroPharma and Schering-Plough Enter Into Agreement For New Intranasal Formulation of Pleconaril
25 nov. 2003 12h40 HE
|
ViroPharma Incorporated
EXTON, Pa. and KENILWORTH, N.J., Nov. 25, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) and Schering-Plough Corporation (NYSE:SGP) today announced that the companies have entered into an...
ViroPharma Incorporated Reports Third Quarter Financial Results
06 nov. 2003 16h58 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 6, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the quarter ended September 30, 2003.
For the quarter ended September 30,...
ViroPharma Awarded Two SBIR Grants for Biodefense Antiviral Drug Discovery Programs
01 oct. 2003 10h05 HE
|
ViroPharma Incorporated
EXTON, Pa., Oct. 1, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it was awarded two Phase 1 Small Business Innovation Research (SBIR) grants from the National...
ViroPharma Incorporated Reports Second Quarter Financial Results
14 août 2003 10h52 HE
|
ViroPharma Incorporated
EXTON, Pa., August 14, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the quarter ended June 30, 2003.
For the quarter ended June 30, 2003, the...
ViroPharma Licenses Rights from GlaxoSmithKline for Product Candidate for Cytomegalovirus (CMV) in Immunocompromised Patients
11 août 2003 07h30 HE
|
ViroPharma Incorporated
EXTON, Pa., Aug. 11, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the acquisition of worldwide rights (excluding Japan) from GlaxoSmithKline (GSK) to an antiviral...
ViroPharma Lead Compounds Show Potent Activity Against Smallpox Virus
30 juil. 2003 07h30 HE
|
ViroPharma Incorporated
EXTON, Pa., July 30, 2003 (PRIMEZONE) -- VIROPHARMA INCORPORATED (Nasdaq:VPHM) today announced that compounds from its lead chemical series, recently shown to have potent antiviral activity against a...
ViroPharma Announces Results of Hepatitis C Phase 1b Study
15 juil. 2003 16h45 HE
|
ViroPharma Incorporated
EXTON, Pa., July 15, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced results from the treatment portion of a phase 1b study with HCV-371, a hepatitis C antiviral compound...